VA launches trial of GLP-1 treatment for alcohol use disorder
VA launches trial of GLP-1 treatment for alcohol use disorder By Staff The U.S. Department of Veterans Affairs today announced a new clinical trial to evaluate the efficacy of semaglutide, a GLP-1 receptor agonist used ...
Read more →





